C3 Cannabinoid Compound - Ownership and Business Overview

Life ScienceCompany

C3 Cannabinoid Compound Ownership

Who owns C3 Cannabinoid Compound?

C3 Cannabinoid Compound is owned by Dermapharm Holding SE. It was acquired on December 15, 2021.

C3 Cannabinoid Compound Business Overview

Where is C3 Cannabinoid Compound headquartered?

C3 Cannabinoid Compound is headquartered in Neumarkt, Germany.

What sector is C3 Cannabinoid Compound in?

C3 Cannabinoid Compound is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 392 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 346 by strategics.

C3 Cannabinoid Compound

C³ Cannabinoid Compound Company GmbH

Kerschensteinerstraße 11-15,
Neumarkt, 92318
Germany,
www.c3-company.de

C3 Cannabinoid Compound develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany, THC Pharm GmbH The Health Concept, based in Frankfurt, Germany, and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for C3 Cannabinoid Compound

Life Science Companies , Germany Companies